• Explore /
  • Poster
  • / Phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma.

Phase 1b/2 study of tivozanib in patients with advanced inoperable hepatocellular carcinoma.

Abstract Poster

Authors

Sunyoung Lee

Sunyoung S. Lee

Roswell Park Cancer Institute, Buffalo, NY

Sunyoung S. Lee , Austin Miller , Smitha S. Krishnamurthi , Bassam N. Estfan , Andrea Frazer , Chong Wang , Renuka V. Iyer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01835223

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 364)

DOI

10.1200/JCO.2018.36.4_suppl.364

Abstract #

364

Poster Bd #

H1

Abstract Disclosures

Similar Posters

First Author: Renuka V. Iyer

Poster

2018 ASCO Annual Meeting

Phase II study of pembrolizumab in advanced, unresectable hepatocellular carcinoma.

Phase II study of pembrolizumab in advanced, unresectable hepatocellular carcinoma.

First Author: Lynn G. Feun

First Author: Masatoshi Kudo

First Author: Andrew Johns